Loading…
Reported covered position: Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2026 · third_quarter · Q3
S.1164 & H.R.1397-Increaseing Access to Dental Insurance Act; H.R.7931-Improving Dental Administration Act of 2026; H.R. 1521-Dental and Optometric Care Access Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| LUPIN PHARMACEUTICALS INC |
| 9 |
| 2019–2020 |
| THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) | 8 | 2025–2026 |
| Akorn, Inc. | 3 | 2022 |
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S.1164 & H.R.1397-Increaseing Access to Dental Insurance Act; H.R.7931-Improving Dental Administration Act of 2026; H.R. 1521-Dental and Optometric Care Access Act of 2025.
DOC Access Act of 2025
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S.1164 & H.R.1397-Increaseing Access to Dental Insurance Act; H.R.7931-Improving Dental Administration Act of 2026; H.R. 1521-Dental and Optometric Care Access Act of 2025.
IDA Act of 2026
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S.1164 & H.R.1397-Increaseing Access to Dental Insurance Act; H.R.7931-Improving Dental Administration Act of 2026; H.R. 1521-Dental and Optometric Care Access Act of 2025.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S.1164 & H.R.1397-Increaseing Access to Dental Insurance Act; H.R.7931-Improving Dental Administration Act of 2026; H.R. 1521-Dental and Optometric Care Access Act of 2025.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Consolidated Appropriations Act(CAA)of 2026 (P.L. 119-75); S. 2355-Patients Deserve Price Tag Act.
S. 2355-Patients Deserve Price Tag Act; Consolidated Appropriations Act(CAA)of 2026 (P.L. 119-75); Department of Labor Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure Proposed Rule (RIN-1210-AB37)
Break Up Big Medicine Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
Education related to issues confronting independent physicians, including S. 3822-Break up Big Medicine Act. General issues related to pharmaceutical supply chain.
Break Up Big Medicine Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
Education related to issues confronting independent physicians, including S. 3822-Break up Big Medicine Act. General issues related to pharmaceutical supply chain.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R.2214-The DRUG Act; H.R.1-One Big, Beautiful Bill Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R.1397-To allow additional individuals to enroll in standalone dental plans offered through Federal Exchanges.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
H.R.2214-The DRUG Act.
H.R.2214-The DRUG Act.
H.R. 2214-The DRUG Act
H.R.2214-The DRUG Act; H.R.1-One Big, Beautiful Bill Act.
Lower Health Care Premiums for All Americans Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
S.891-The Bipartisan Health Care Act; H.R.6703-Lower Health Care Premiums for All Americans Act; S.3345-PBM Price Transparency and Accountability Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) · Firm: GOVERNMENT COUNSEL, LLC
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
PBM Price Transparency and Accountability Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
S.891-The Bipartisan Health Care Act; H.R.6703-Lower Health Care Premiums for All Americans Act; S.3345-PBM Price Transparency and Accountability Act.
S. 891-The Bipartisan Health Care Act.
S. 891-The Bipartisan Health Care Act
S.891-The Bipartisan Health Care Act; H.R.6703-Lower Health Care Premiums for All Americans Act; S.3345-PBM Price Transparency and Accountability Act.
S. 891-The Bipartisan Health Care Act
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
H.R. 10445-Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025.
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000/HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment. H.R. 10445-"Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025"regarding Sec. 224. Medicare coverage of multi-cancer early detection screening tests.
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 10445-Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025 relating to Division E Healthcare.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: MEDTRONIC INC. · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023;
VALID Act of 2023
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
VALID Act of 2023
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
Issues related to clinical diagnostic laboratory services; issues related to public health emergency and pandemic preparedness; H.R. 2369-VALID Act of 2023.
VALID Act of 2023
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
VALID Act of 2023
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment.
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000/H.R.2377-Saving Access to Laboratory Services Act (SALSA).
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000/HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment. H.R. 10445-"Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025"regarding Sec. 224. Medicare coverage of multi-cancer early detection screening tests.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Lower Costs, More Transparency Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Lower Costs, More Transparency Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Lower Costs, More Transparency Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Seniors’ Access to Critical Medications Act of 2024
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Seniors’ Access to Critical Medications Act of 2024
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Telehealth Modernization Act of 2024
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment.
Telehealth Modernization Act of 2024
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Telehealth Modernization Act of 2024
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Telehealth Modernization Act of 2024
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Telehealth Modernization Act of 2024
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000/HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment. H.R. 10445-"Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025"regarding Sec. 224. Medicare coverage of multi-cancer early detection screening tests.
Heart Health Enhancement through Access to Research and Training Act
Client: MEDTRONIC INC. · Firm: GOVERNMENT COUNSEL, LLC
H.R. 880-Heart Health Enhancement through Access to Research and Training Act.
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000/H.R.2377-Saving Access to Laboratory Services Act (SALSA).
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000/HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment. H.R. 10445-"Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025"regarding Sec. 224. Medicare coverage of multi-cancer early detection screening tests.
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment.
Saving Access to Laboratory Services Act
Client: HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) · Firm: GOVERNMENT COUNSEL, LLC
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Pharmacy Benefit Manager Reform Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Pharmacy Benefit Manager Reform Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Pharmacy Benefit Manager Reform Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Pandemic and All-Hazards Preparedness and Response Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Pandemic and All-Hazards Preparedness and Response Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Pandemic and All-Hazards Preparedness and Response Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Pandemic and All-Hazards Preparedness and Response Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE · Firm: GOVERNMENT COUNSEL, LLC
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Modernizing and Ensuring PBM Accountability Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Modernizing and Ensuring PBM Accountability Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs.
Modernizing and Ensuring PBM Accountability Act
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs.
Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client: PRIME THERAPEUTICS · Firm: GOVERNMENT COUNSEL, LLC
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
National Defense Authorization Act for Fiscal Year 2025
Client: APOTEX CORPORATION · Firm: GOVERNMENT COUNSEL, LLC
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
National Defense Authorization Act for Fiscal Year 2025
Client: APOTEX CORPORATION · Firm: GOVERNMENT COUNSEL, LLC
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
National Defense Authorization Act for Fiscal Year 2025
Client: MEDTRONIC INC. · Firm: GOVERNMENT COUNSEL, LLC
S. 4638-National Defense Authorization Act for Fiscal Year 2025 (NDAA) regarding the right to repair by third party servicers.
National Defense Authorization Act for Fiscal Year 2025
Client: APOTEX CORPORATION · Firm: GOVERNMENT COUNSEL, LLC
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Issues relating to medical device cybersecurity and artificial intelligence. S. 4697-Healthcare Cybersecurity Act of 2024.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Increasing Access to Dental Insurance Act
Client: DELTA DENTAL OF CALIFORNIA · Firm: GOVERNMENT COUNSEL, LLC
H.R. 1671-Increasing Access to Dental Insurance Act.
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2026 · third_quarter · Q3
Education related to issues confronting independent physicians, including S. 3822-Break up Big Medicine Act. General issues related to pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2026 · second_quarter · Q2
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2026 · second_quarter · Q2
Education related to issues confronting independent physicians, including S. 3822-Break up Big Medicine Act. General issues related to pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2026 · second_quarter · Q2
Consolidated Appropriations Act(CAA)of 2026 (P.L. 119-75); S. 2355-Patients Deserve Price Tag Act.
Filing targets: SENATE
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2026 · second_quarter · Q2
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2026 · first_quarter · Q1
S. 2355-Patients Deserve Price Tag Act; Consolidated Appropriations Act(CAA)of 2026 (P.L. 119-75); Department of Labor Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure Proposed Rule (RIN-1210-AB37)
Filing targets: HOUSE OF REPRESENTATIVES
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2026 · first_quarter · Q1
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2026 · first_quarter · Q1
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2026 · first_quarter · Q1
General issues related to drug shortages and health care costs in the pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2025 · fourth_quarter · Q4
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2025 · fourth_quarter · Q4
H.R.2214-The DRUG Act.
S.891-The Bipartisan Health Care Act; H.R.6703-Lower Health Care Premiums for All Americans Act; S.3345-PBM Price Transparency and Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2025 · fourth_quarter · Q4
General issues related to drug shortages and the Strategic National Stockpile.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2025 · fourth_quarter · Q4
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2025 · third_quarter · Q3
General Issues related to drug shortages.
General issues related to pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2025 · third_quarter · Q3
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2025 · third_quarter · Q3
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2025 · third_quarter · Q3
H.R.2214-The DRUG Act.
S. 891-The Bipartisan Health Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2025 · second_quarter · Q2
H.R.2214-The DRUG Act; H.R.1-One Big, Beautiful Bill Act.
S. 891-The Bipartisan Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2025 · second_quarter · Q2
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2025 · second_quarter · Q2
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2025 · second_quarter · Q2
General Issues related to drug shortages.
Issues relating to the Physician Self-Referral Law exceptions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2025 · first_quarter · Q1
H.R. 2214-The DRUG Act
S. 891-The Bipartisan Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2025 · first_quarter · Q1
S. 1164 & H.R. 1397-Increaseing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2025 · first_quarter · Q1
General Issues Related to Drug Shortages.
Implementation of Public Law 113-54 (DSCSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2025 · first_quarter · Q1
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THORN RUN PARTNERS (OBO DELTA DENTAL PLANS ASSOCIATION) via GOVERNMENT COUNSEL, LLC
2025 · first_quarter · RR
Issues related to promoting affordability and access to dental health care.
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2025 · first_quarter · 1T
H.R.1397-To allow additional individuals to enroll in standalone dental plans offered through Federal Exchanges.
Filing targets: HOUSE OF REPRESENTATIVES
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2024 · fourth_quarter · 4A
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Federal policy relating to strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2024 · fourth_quarter · Q4
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Federal policy relating to strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2024 · fourth_quarter · Q4
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
H.R. 10445-Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2024 · fourth_quarter · Q4
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2024 · fourth_quarter · Q4
H.R. 10445-Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025 relating to Division E Healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2024 · fourth_quarter · 4T
S.1000/HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment. H.R. 10445-"Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025"regarding Sec. 224. Medicare coverage of multi-cancer early detection screening tests.
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2024 · third_quarter · Q3
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2024 · third_quarter · Q3
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2024 · third_quarter · Q3
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2024 · third_quarter · Q3
Issues relating to the prevention and mitigation of pharmaceutical shortages.
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2024 · third_quarter · Q3
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Federal policy relating to strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2024 · third_quarter · Q3
S. 4638-National Defense Authorization Act for Fiscal Year 2025 (NDAA) regarding the right to repair by third party servicers.
Issues relating to medical device cybersecurity and artificial intelligence. S. 4697-Healthcare Cybersecurity Act of 2024.
Filing targets: SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2024 · second_quarter · Q2
H.R. 880-Heart Health Enhancement through Access to Research and Training Act.
H.R. 1691-Ensuring Patient Access to Critical Breakthrough Products Act of 2023;
Issues related to the sterilization of medical devices.
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2024 · second_quarter · Q2
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2024 · second_quarter · Q2
Issues relating to the prevention and mitigation of pharmaceutical shortages.
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2024 · second_quarter · Q2
Federal policy relating to strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2024 · second_quarter · Q2
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2024 · second_quarter · Q2
S.1000 / HR 2377-Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment.
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2024 · first_quarter · Q1
Issues relating to medical device cybersecurity and artificial intelligence.
Issues related to the sterilization of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2024 · first_quarter · Q1
Federal policy relating to market access barriers for generic pharmaceuticals, strengthening domestic generic production and addressing drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2024 · first_quarter · Q1
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2024 · first_quarter · Q1
Issues related to clinical diagnostic laboratory services; issues related to public health emergency and pandemic preparedness; H.R. 2369-VALID Act of 2023.
S.1000/H.R.2377-Saving Access to Laboratory Services Act (SALSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2024 · first_quarter · Q1
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs.
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2024 · first_quarter · Q1
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Issues relating to the prevention and mitigation of pharmaceutical shortages.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2023 · fourth_quarter · Q4
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2023 · fourth_quarter · Q4
Issues related to clinical diagnostic laboratory services; issues related to public health emergency and pandemic preparedness; H.R. 2369-VALID Act of 2023.
S.1000/H.R.2377-Saving Access to Laboratory Services Act (SALSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2023 · fourth_quarter · Q4
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2023 · fourth_quarter · Q4
Issues relating to medical device cybersecurity.
Issues relating to medical device shortage reporting.
Issues related to the sterilization of medical devices.
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2023 · fourth_quarter · Q4
Legislative proposals to prevent and respond to drug shortages, including House Energy and Commerce Committee Discussion Draft.
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2023 · fourth_quarter · Q4
Federal policy relating to market access barriers for generic pharmaceuticals, strengthening domestic generic production and addressing drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2023 · third_quarter · Q3
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act.
S. 2973-Modernizing and Ensuring PBM Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2023 · third_quarter · Q3
Monitor domestic pharmaceutical production legislation.
FY2024 NDAA relating to evaluation of current capacity and vulnerabilities of biopharmaceutical manufacturing in the United States.
FY2024 Labor/HHS appropriations relating to ASPR Manufacturing and Production and Pandemic Preparedness and Biodefense activities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2023 · third_quarter · Q3
H.R. 501-Block, Report, And Suspend Suspicious Shipments Act. Legislative proposals to prevent and respond to drug shortages.
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2023 · third_quarter · Q3
H.R. 1671 and S.2771-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2023 · third_quarter · Q3
H.R.2377-Saving Access to Laboratory Services Act (SALSA).
Issues related to clinical diagnostic laboratory services; issues related to public health emergency and pandemic preparedness; H.R. 2369-VALID Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2023 · third_quarter · Q3
Monitor device shortage reporting issues related to the reauthorization of Pandemic and All Hazards Preparedness Act.
Monitor issues related to the sterilization of medical devices.
Issues related to Medicare coverage and payment for breakthrough medical devices.
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2023 · second_quarter · Q2
H.R. 1671-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2023 · second_quarter · Q2
Issues related to clinical diagnostic laboratory services; issues related to public health emergency and pandemic preparedness; H.R. 2369-VALID Act of 2023.
S.1000/H.R.1835-Saving Access to Laboratory Services Act (SALSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2023 · second_quarter · Q2
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act, H.R.4508-Hidden Fee Disclosure Act, H.R. 3561-The Patient Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2023 · second_quarter · Q2
Monitor device shortage reporting issues related to the reauthorization of Pandemic and All Hazards Preparedness Act.
Monitor issues relating to medical device cybersecurity.
Monitor issues related to the sterilization of medical devices.
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2023 · second_quarter · Q2
S.2333-Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421-Preparing for All Hazards and Pathogens Reauthorization Act; Implementation of Public Law 113-54 (DSCSA).
H.R. 501-Block, Report, And Suspend Suspicious Shipments Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2023 · second_quarter · Q2
Issues relating to the structure of the Hatch-Waxman Act's 180-day exclusivity provision (S.1114). Monitor domestic pharmaceutical production legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2023 · first_quarter · Q1
H.R. 1671-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2023 · first_quarter · Q1
Issues relating to prescription benefit manager transparency; S.127-Pharmacy Benefit Manager Transparency Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2023 · first_quarter · Q1
H.R.2369-VALID Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2023 · first_quarter · Q1
Monitor issues related to the sterilization of medical devices.
Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke
Monitor issues relating to medical device cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2023 · first_quarter · Q1
Reauthorization of the Pandemic All-Hazards Preparedness Act; Implementation of Public Law 113-54 (DSCSA).
H.R. 501-Block, Report, And Suspend Suspicious Shipments Act; General issues relating access to medication assisted treatment.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2023 · first_quarter · Q1
Issues relating to the structure of the Hatch-Waxman Act's 180-day exclusivity provision.
Filing targets: SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
Monitor Environmental, Social and Governance (ESG) issues relating to the health sector.
Monitor issues relating to medical device cybersecurity.
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to S. 4348 (FDASLA Act of 2022), H.R. 7667 (Food and Drug Amendments of 2022), S.3799 (PREVENT Pandemics Act), Certificate to Foreign Government (CFG) and FDA device shortage reporting authority.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
S. 4739-Increasing Access to Dental Insurance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to Medicare payment rates for clinical diagnostic laboratory services (H.R. 8188/S.4449-SALSA) and regulation of laboratory developed tests (FDASLA Act of 2022).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
Public Law 117-328-Consolidated Appropriations Act, 2023, relating oversight of PBM services and S.4293 (Pharmacy Benefit Manager Transparency Act of 2022).
Filing targets: SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to strategic national stockpile issues and The PREVENT Pandemics Act (S.3799).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to 180-day exclusivity reform in S. 4348 (FDASLA Act of 2022).
Filing targets: SENATE
AKORN, INC. via GOVERNMENT COUNSEL, LLC
2022 · fourth_quarter · Q4
CARES Act Section 2305(B) refundable credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
Revisions to Payment Policies under the Medicare Physician Fee Schedule Quality Payment Program and Other Revisions to Part B for CY 2023 regarding payment of dental services.
S. 4739-Increasing Access to Dental Insurance Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AKORN, INC. via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
CARES Act Section 2305(B) refundable credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests.
H.R. 8188/S.4449-Saving Access to Laboratory Services Act (SALSA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
General issues relating to oversight of PBM services, government negotiated drug pricing and Part D cost sharing; The Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS‐4192‐P) Proposed Rule relating to pharmacy direct and indirect remuneration.
S. 2199-Insulin Price Reduction Act; S.4293-Pharmacy Benefit Manager Transparency Act of 2022; S. 1388-Prescription Pricing for the People Act of 2021.
Monitor issues relating to insulin pricing in the Inflation Reduction Act (H.R. 5376).
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
Monitor issues relating to negotiating Medicare prescription drug prices in the Inflation Reduction Act (H.R. 5376).
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act relating to 180-day exclusivity reform.
Filing targets: SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
General Issues related to strategic national stockpile; S.3799-The PREVENT Pandemics Act; H.R. 2870-Essential Medicines Strategic Stockpile Act of 2021.
General issues related to opioid medication assisted treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · Q3
CHIPS Act of 2022 (P.L. 117-167)
Monitoring issues relating to medical device cybersecurity.
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667-The Food and Drug Amendments of 2022; Issues relating to the Certificate to Foreign Government (CFG) and FDA device shortage reporting authority.
AKORN, INC. via GOVERNMENT COUNSEL, LLC
2022 · third_quarter · RR
CARES Act Section 2305(B) refundable credit
DELTA DENTAL OF CALIFORNIA via GOVERNMENT COUNSEL, LLC
2022 · second_quarter · Q2
Policies related to the operation of the Affordable Care Act Exchanges, including independent purchase of dental benefits.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2022 · second_quarter · Q2
General issues relating to oversight of PBM services, government negotiated drug pricing and Part D cost sharing; The Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS‐4192‐P) Proposed Rule relating to pharmacy direct and indirect remuneration.
S. 2199-Insulin Price Reduction Act; S.4293-Pharmacy Benefit Manager Transparency Act of 2022; S. 1388-Prescription Pricing for the People Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC. via GOVERNMENT COUNSEL, LLC
2022 · second_quarter · Q2
Monitoring issues relating to medical device cybersecurity. H.R.7084 and S.3983-PATC Act.
Issues related to stroke care and transportation protocols for stroke victims.
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act; H.R. 7667-The Food and Drug Amendments of 2022; Issues relating to the Certificate to Foreign Government (CFG) and FDA device shortage reporting authority.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via GOVERNMENT COUNSEL, LLC
2022 · second_quarter · Q2
General issues related to opioid medication assisted treatment; Implementation of Public Law 113-54 (DSCSA).
General Issues related to strategic national stockpile; S.3799-The PREVENT Pandemics Act; H.R. 2870-Essential Medicines Strategic Stockpile Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2022 · second_quarter · Q2
Monitoring issues relating to strengthening domestic manufacturing of active pharmaceutical ingredients and finished dosages.
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act relating to 180-day exclusivity reform. S.2910 - Expanding Access to Low-Cost Generics Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) via GOVERNMENT COUNSEL, LLC
2022 · second_quarter · Q2
S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests.
General issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX CORPORATION via GOVERNMENT COUNSEL, LLC
2022 · first_quarter · Q1
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act.
Monitoring issues relating to strengthening domestic manufacturing of active pharmaceutical ingredients and finished dosages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via GOVERNMENT COUNSEL, LLC
2022 · first_quarter · Q1
General issues relating to oversight of PBM services, government negotiated drug pricing and Part D cost sharing; The Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS‐4192‐P) Proposed Rule relating to pharmacy direct and indirect remuneration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to medical device cybersecurity and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES
Issues related to Medicare coverage and payment for breakthrough medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor issues relating to medical device cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Inflation Reduction Act (H.R. 5376).
Monitor Environmental, Social and Governance (ESG) issues relating to the health sector.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE